B+
Bull case
20%
Probability
Target price
$205.00
Analysis reference price unavailable
Analysis 2026-07-30 · RankAlpha Sentiment Codex
UHS
Universal Health ServicesBNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$180.00
Analysis reference price unavailable
Analysis 2026-07-30 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$145.00
Analysis reference price unavailable
Analysis 2026-07-30 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-07-30
Recent news sentiment (30D)
-0.3
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+63.4
Score
AI commentary
Post-earnings tone is negative despite reported Q2 results exceeding the stored pre-print estimates: Reuters-syndicated secondary coverage reported shares down 7.1% after the release and linked the reaction to below-consensus full-year guidance and reimbursement concerns. The company release reports 2026 diluted EPS of $5.98 and no Q2 2026 adjustments, so no adjusted-EPS miss claim is retained. The 2026-07-29 anchor price was $168.16. Post-print analyst target and estimate revisions are unavailable, the analyst-target count is missing, and social coverage is absent, so confidence remains moderate rather than high.
RankAlpha Sentiment Codex - 2026-07-30
Open post-earnings memoEvidence flagged
high-coverage report lacks a dated company-specific catalyst beyond generic cadence; later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence
Impact
tentative
Confidence
-
AI events
2026-07-27eventJuly 27 Q2 release: strong reported results but FY26 profit outlook reducedMedium impact
The company reported Q2 revenue of $4.638 billion, up 8.3% year over year, and diluted EPS of $5.98. Stored pre-print Zacks estimates were $4.52 billion of revenue and $5.66 EPS. UHS revised FY26 adjusted EPS to $22.28-$23.65, with the midpoint 2.6% below the original forecast; adjusted EBITDA midpoint fell 1.9%. The Florida Medicaid payment benefit was also largely nonrecurring. [#SEC-8K-2026-07-28] [#PR-EARNINGS-2026-07-22]
2026-10-28eventTalkspace acquisition expected to finalize in Q3 2026Medium impact
UHS expects to finalize its Talkspace acquisition during Q3 2026, with up to $400 million of delayed-draw financing available at closing. The transaction could expand behavioral-health capabilities, but integration and financing execution remain material uncertainties. [#SEC-8K-2026-07-28]
2027-07-30catalystSustained same-facility operating growthHigh impact
Q2 same-facility acute-care revenue rose 8.2%, supported by 2.9% adjusted-admission growth and higher revenue per admission; behavioral-health revenue rose 7.4%. Persistence of these trends could support earnings, although Q2 included a significant Florida Medicaid benefit. [#SEC-8K-2026-07-28]
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-30 • Updated nightlySource: Internal modelMethodology